Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T19777 |
ODQ
|
Apoptosis; Others; Guanylate cyclase | Apoptosis; GPCR/G Protein; Others |
ODQ 是一种选择性可溶性的鸟苷酰环化酶抑制剂,可增强顺铂促人间皮瘤细胞凋亡的作用。 | |||
T9954 |
K-975
|
Others | Others |
K-975是一种高选择性的具有口服活性的TEAD 抑制剂,可有效抑制TEAD 和YAP1/TAZ 之间的蛋白质-蛋白质相互作用。 | |||
T21505 |
Suberoyl bis-hydroxamic acid
SBHA,软木肟酸,Suberohydroxamic acid |
Apoptosis; HDAC | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair |
Suberoyl bis-hydroxamic acid (SBHA) 是一种竞争性且可透过细胞的HDAC1和HDAC3抑制剂,ID50值分别为 0.25 μM 和 0.30 μM。它使肿瘤细胞易于凋亡并促进线粒体凋亡途径,可研究甲状腺髓样癌。 | |||
T76815 |
Lexatumumab
ETR2-ST01,DR5 mAB,HGS-ETR 2 |
Apoptosis | Apoptosis |
Lexatumumab (HGS-ETR 2) 是一种靶向 TRAIL 受体 2 的人激动性单克隆抗体,具有抗癌活性, 在恶性间皮瘤中诱导细胞凋亡 (apoptosis)。Lexatumumab 可用于研究恶性胸膜间皮瘤 (MPM)。 | |||
T76857 |
Anetumab
|
Others | Others |
Anetumab 是一种新型全人源抗间皮素 IgG1抗体,是 Anetumab ravtansine的裸抗。Anetumab 可用于合成抗体-活性分子偶联物 Anetumab ravtansine。Anetumab 可用于研究治疗转移性胸膜间皮瘤。 | |||
T1844 |
KPT330,(E)-
(E)-RN,KPT-330,KPT330,KPT 330 |
Others; CRM1 | Membrane transporter/Ion channel; Others |
(E)-RN (KPT 330) 是一种 CRM1 选择性核输出抑制剂。它抑制细胞核中的蛋白质运输并诱导间皮瘤细胞中的细胞周期停滞和凋亡。 | |||
T0189L |
Pemetrexed disodium
培美曲塞二钠盐,LY-231514,LY231514 disodium,培美曲塞二钠,Pemetrexed |
Apoptosis; DHFR; DNA/RNA Synthesis; Antifolate; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
Pemetrexed disodium (LY-231514) 是一种叶酸拮抗剂,用于治疗非小细胞肺癌和恶性间皮瘤。它抑制胸苷酸合成酶,二氢叶酸还原酶和甘氨酰胺核苷酸甲酰转移酶的Ki 分别为 1.3 nM,7.2 nM 和 65 nM。 | |||
T25929 |
Pemetrexed tromethamine
Pemetrexed ditromethamine dihydrate |
||
Pemetrexed tromethamine is a chemotherapy drug used for pleural mesothelioma and non-small cell lung cancer. | |||
T32344 |
JY-1-106
JY-1 106,JY-1106 |
||
JY-1-106 is a BH3 α-helix mimetic, inducing apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak. | |||
T68934 | VT101 free base | ||
VT101 is a TEAD Auto-palmitoylation inhibitor that Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. VT101 inhibited the firefly luciferase reporter dose-dependently and had no 204 effect on the Renilla luciferase reporter. | |||
T71424 | VT-102 free base | ||
VT-102 is a TEAD Auto-palmitoylation inhibitor that Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. VT102 inhibited the firefly luciferase reporter dose-dependently and had no 204 effect on the Renilla luciferase reporter. |